Global Neural Implants Markets 2020-2025: The Emergence of Latest Generation Neural Implants / Promising Rise of Investigational Devices / Growing Popularity of MR-conditional Neural Implants

Dublin, Nov. 10, 2020 (GLOBE NEWSWIRE) -- The "Neural Implants Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

The neural implants market by revenue is expected to grow at a CAGR of 11% during the period 2020-2025.

The global brain implants market is one of the fastest-growing segments in the global neurological treatment devices industry. The growing prevalence of neurological diseases worldwide, coupled with rising awareness among patients about new treatment modalities for neurological disorders and the increasing availability of effective devices, is a major factor contributing to the industry growth.

Neural implant technology is highly innovative and is expected to influence the existing treatment modalities of neuropathic disorders and chronic neuropathic pain. The introduction of neural implants has been a significant breakthrough in neurological treatment modalities with their high potential in minimizing the occurrence of adverse events associated with Parkinson's Disease, chronic pain, epilepsy, and other neural disorders. Therefore, the adoption of neural implants is likely to increase at a phenomenal rate in the coming years.

Global Neural Implants Market Segmentation

This research report includes a detailed segmentation by product, end-users, application, geography. In 2019, the spinal cord stimulation (SCS) segment accounted for more than 62% of the global neural implants market share. The growth of the segment has been fueled primarily due to the increasing prevalence of neuropathic pain, particularly the upsurge of patients with failed back surgery syndrome (FBSS)/failed back syndrome (FBS), and the attempts to use strategies other than chronic opioid therapy for the treatment of chronic neuropathic pain. Implantable SCS systems are used to treat certain types of chronic pain, such as neuropathic pain. As an intervention for chronic pain, SCS has proven an effective alternative.

The chronic pain segment will cross USD 4 billion by 2025. According to the WHO, an estimated 22% of the world's primary care patients have chronic debilitating pain making chronic pain a global challenge to be addressed by healthcare professionals. The incidence/prevalence of chronic pain is increasing rapidly worldwide. It affects 28-65% of the population in the US. Developing countries face a large burden of chronic pain than developed regions. Thus, the rising burden of chronic pain is likely to fuel the growth of the segment.

In 2019, hospitals' end-user segment constituted over 56% of the global neural implants market share. Healthcare professionals in hospitals are using neural implants for treating symptoms associated with neuropathic pain and neurodegenerative disorders. The industry is growing at a healthy rate and is likely to grow during the forecast period. The high adoption of the latest generation implants and the increased preference among patients with an increased risk of neurological diseases for visiting hospitals for diagnosis and treatment contribute to the segment's growth.

Insights by Vendors

The global neural implants market share is highly consolidated, with major vendors accounting for dominant shares. Key vendors are offering a broad range of conventional as well as latest-generation neural implants for end-users. Medtronic, Abbott, Boston Scientific, NEVRO, and LivaNova are the key players in the industry.

These vendors compete based on technology advances, accuracy features, regulatory approvals, marketing strategies, and distribution channels. These companies have a wide geographic footprint, diversified product portfolio, and a strong focus on product innovation, strategic mergers & acquisitions, and R&D activities.

Prominent Vendors

• Medtronic

• Abbott

• Boston Scientific

• NEVRO

• LivaNova

Other Prominent Vendors

• Aleva Neurotherapeutics

• Beijing PINS Medical

• Nalu Medical

• NeuroPace

• Nuvectra

• Saluda Medical

• SceneRay

• Stimwave

Investigational Companies

• GTX Medical

• MicroTransponder

• Neuralink

• SetPoint Medical

• Synchron

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of the Study
4.4 Market Segments

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Neural Implants: An Overview

8 Market Opportunities & Trends
8.1 Emergence of Latest Generation Neural Implants
8.2 Promising Investigational Devices
8.3 New Product Approvals/Launches

9 Market Growth Enablers
9.1 Rising Target Patient Pool Globally
9.2 Growing Popularity of MR-Conditional Neural Implants
9.3 Increasing Uptake of Minimally Invasive Pain Relief Treatment
9.4 Use of High-Frequenecy Neuromodulation Therapy

10 Market Restraints
10.1 Risks & Complications Associated With Neural Implants
10.2 Stringent Regulations Associated With Neural Implants
10.3 Limited Availability of Skilled Neurologists/Neurosurgeons
10.4 High Cost of Neural Implants

11 Market Landscape
11.1 Market Overview
11.2 COVID-19 Impact on the Global Neural Implants Market
11.3 Market Size & Forecast
11.4 Five Forces Analysis

12 Neural Implants Market by Product
12.1 Snapshot & Growth Engine
12.2 Overview
12.3 SCS
12.4 DBS
12.5 VNS

13 Neural Implants Market by Application
13.1 Snapshot & Growth Engine
13.2 Overview
13.3 Chronic Pain
13.4 Parkinson's Disease
13.5 Epilepsy
13.6 Others

14 Neural Implants Market by End-User
14.1 Snapshot & Growth Engine
14.2 Overview
14.3 Hospitals
14.4 Specialized Neurological Centers
14.5 Outpatient Surgery Centers

15 Neural Implants Market by Geography
15.1 Snapshot & Growth Engine
15.2 Geographic Overview

For more information about this report visit https://www.researchandmarkets.com/r/c99uq5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900